European Healthtech startup funding raised during Q3 2020.
In Q3 2020, 167 European Healthtech companies raised a combined €2.1B across 169 funding rounds, up 115.9% versus Q3 2019. UK led by capital raised, and Bpifrance was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Freeline Therapeutics | Series C | Jul 2020 | €107M |
| Sophia Genetics | Series D+ | Sep 2020 | €94M |
| Neogene Therapeutics | Other | Sep 2020 | €93M |
| Freeline Therapeutics | Series C |
8 exits · €200M disclosed.
| Nanox Imaging | IPO | Aug 2020 | €140M |
| Fiagon | Acquisition | Sep 2020 | €60M |
| Jul 2020 |
| €71M |
| Lava Therapeutics | Series C | Sep 2020 | €70M |
| Melio | Series C | Sep 2020 | €68M |
| Sight Diagnostics | Series D+ | Jul 2020 | €61M |
| Sight | Series D+ | Aug 2020 | €60M |
| Imcheck Therapeutics | Other | Sep 2020 | €54M |
| F2G | Other | Aug 2020 | €52M |
| WiThings | Series B | Jul 2020 | €51M |
| DNA Script | Series B | Jul 2020 | €46M |
| TytoCare | Early VC | Jul 2020 | €45M |
| Indigo Diabetes | Series B | Jul 2020 | €38M |
| ReViral | Series C | Aug 2020 | €37M |
